Atara Biotherapeutics (ATRA) Depreciation and Depletion (2013 - 2025)
Atara Biotherapeutics (ATRA) posted Depreciation and Depletion of $100000.0 for Q4 2025, down 66.67% on a QoQ basis from $300000.0 in Q1 2025, and down 80.0% year-over-year from $500000.0 in Q4 2024.
Atara Biotherapeutics (ATRA) Depreciation and Depletion (2013 - 2025) Analysis & Trends
Atara Biotherapeutics' Depreciation and Depletion history runs 9 years deep, the most recent figure standing at $100000.0 for Q4 2025.
- Quarterly Depreciation and Depletion fell 80.0% year-over-year to $100000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $400000.0 (down 85.19% YoY) and the FY2025 annual result came in at $400000.0, down 85.19% from the prior year.
- Depreciation and Depletion was $100000.0 for Q4 2025 at Atara Biotherapeutics, down from $300000.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $1.5 million in Q1 2022 and bottomed at $100000.0 in Q4 2025.
- A 4-year average of $828571.4 and a median of $900000.0 in 2022 frame the typical range for Depreciation and Depletion.
- Annual changes were most pronounced in 2023 — Depreciation and Depletion changed 0.0% — and 2025, when it sank 80.0%.
- Atara Biotherapeutics' Depreciation and Depletion stood at $900000.0 in 2022, then changed by 0.0% to $900000.0 in 2023, then tumbled by 44.44% to $500000.0 in 2024, then sank by 80.0% to $100000.0 in 2025.
- Business Quant data shows ATRA's Depreciation and Depletion at $100000.0 in Q4 2025, $300000.0 in Q1 2025, and $500000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 39.39 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 2.20 Mn |
| 10 | Atara Biotherapeutics | 110.04 Mn | 101.68 Mn | 392,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 100,000.00 |
| Dec 31, 2025 | 100,000.00 |
| Mar 31, 2025 | 300,000.00 |
| Mar 31, 2025 | 300,000.00 |
| Dec 31, 2024 | 500,000.00 |
| Dec 31, 2024 | 500,000.00 |
| Sep 30, 2024 | 600,000.00 |
| Sep 30, 2024 | 600,000.00 |
| Jun 30, 2024 | 700,000.00 |
| Jun 30, 2024 | 700,000.00 |
| Mar 31, 2024 | 900,000.00 |
| Mar 31, 2024 | 900,000.00 |
| Dec 31, 2023 | 900,000.00 |
| Dec 31, 2023 | 900,000.00 |
| Sep 30, 2023 | 900,000.00 |
| Sep 30, 2023 | 900,000.00 |
| Jun 30, 2023 | 900,000.00 |
| Jun 30, 2023 | 900,000.00 |
| Mar 31, 2023 | 900,000.00 |
| Mar 31, 2023 | 900,000.00 |